June 18, 2025
5 min watch
CHICAGO — On this video, Sonali M. Smith, MD, discusses a number of notable research on new remedy combos and different choices for sufferers with lymphoma, which had been introduced at ASCO Annual Assembly.
“We’re persevering with to see themes constructing upon the position of circulating tumor DNA in sufferers with aggressive lymphomas, we’re seeing efforts to construct upon particular salvage regimens, akin to R-GemOx, and we’re seeing new medication come by like antibody-drug conjugates and bispecific antibodies which are being examined both in new settings or in new combos or with longer follow-up,” Smith, Elwood V. Jensen Professor of Drugs and chief of the part of hematology and oncology at College of Chicago Drugs, stated.
